This finding highlights the importance of prolonged treatment Inhibiting cancer cell metastasis when targeting adhesion Ihnibiting to inhibit metastasis effectively. The Transwell insert was separated from the well plate and washed twice with cold PBS. Origins of lymphatic and distant metastases in human colorectal cancer.

Inhibiting cancer cell metastasis -

Acta 12 , — Lin, K. Lohner, J. Large and reversible myosin-dependent forces in rigidity sensing. Lu, C. Novel quinazolinone MJ triggers endoplasmic reticulum stress and intrinsic apoptosis in murine leukemia WEHI-3 cells and inhibits leukemic mice.

PLoS One 7 5 , e Lu, T. Luo, W. Formin DAAM1 organizes actin filaments in the cytoplasmic nodal actin network. PloS one 11 10 , e Analysis of the local organization and dynamics of cellular actin networks. Cell Biol. Lv, J. Cell softness regulates tumorigenicity and stemness of cancer cells.

EMBO J. Meacci, G. α-Actinin links extracellular matrix rigidity-sensing contractile units with periodic cell-edge retractions. Cell 27 22 , — Mitchell, M. Fluid shear stress sensitizes cancer cells to receptor-mediated apoptosis via trimeric death receptors.

New J. Mokhtari, R. Oncotarget 12 15 , — Moore, S. Association of leisure-time physical activity with risk of 26 types of cancer in 1. JAMA Intern. Paszek, M. Tensional homeostasis and the malignant phenotype. Cancer Cell 8 3 , — Qian, B. High miR expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.

Breast Cancer Res. Qin, R. Tumor suppressor DAPK1 catalyzes adhesion assembly on rigid but anoikis on soft matrices. CrossRef Full Text Google Scholar. BioRxivs , Rashid, M. Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform QPOP.

Raval, G. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. Oncogene 22 40 , — Regmi, S. High shear stresses under exercise condition destroy circulating tumor cells in a microfluidic system. Riehl, B. The role of microenvironmental cues and mechanical loading milieus in breast cancer cell progression and metastasis.

Rossier, O. Force generated by actomyosin contraction builds bridges between adhesive contacts. Saxena, M. Force-induced calpain cleavage of talin is critical for growth, adhesion development, and rigidity sensing. Nano Lett. EGFR and HER2 activate rigidity sensing only on rigid matrices.

Sheetz, M. A tale of two states: Normal and transformed, with and without rigidity sensing. Simoes, I. The mystery of mitochondria-ER contact sites in physiology and pathology: A cancer perspective. Basis Dis. Simpson, C. Cancer cells in all EMT states lack rigidity sensing: Depletion of different tumor suppressors causes loss of rigidity sensing in cancer cells.

Google Scholar. Singh, A. Enhanced tumor cell killing by ultrasound after microtubule depolymerization. Tijore, A. Selective killing of transformed cells by mechanical stretch. Biomaterials , Ultrasound-Mediated mechanical forces activate selective tumor cell apoptosis.

BioRxivs , v1. Wang, H. microRNA promotes breast cancer proliferation and metastasis by targeting LZTFL1. BMC Cancer 19 1 , Wang, Q.

Roles and molecular mechanisms of physical exercise in cancer prevention and treatment. Sport Health Sci. Weaver, V. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies.

Wolfenson, H. Tropomyosin controls sarcomere-like contractions for rigidity sensing and suppressing growth on soft matrices. Steps in mechanotransduction pathways that control cell morphology. Wu, S. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H cells through ER stress and caspase cascade- and mitochondria-dependent pathways.

Anticancer Res. PubMed Abstract Google Scholar. Wu, Z. Mitochondrial DNA: Cellular genotoxic stress sentinel. Trends biochem. Yan, F. Role of miR in the growth and metastasis of human salivary adenoid cystic carcinoma. Yang, B. Mechanosensing controlled directly by tyrosine kinases.

Stopping transformed cancer cell growth by rigidity sensing. Yuan, Y. Role of the tumor microenvironment in tumor progression and the clinical applications Review. Keywords: mechanobiology, cancer, mechanosensitivity, transformed growth, cytoskeleton, ultrasound, apoptosis.

Citation: Tijore A, Yang B and Sheetz M Cancer cells can be killed mechanically or with combinations of cytoskeletal inhibitors. doi: Received: 28 May ; Accepted: 12 August ; Published: 10 October Copyright © Tijore, Yang and Sheetz. This is an open-access article distributed under the terms of the Creative Commons Attribution License CC BY.

The use, distribution or reproduction in other forums is permitted, provided the original author s and the copyright owner s are credited and that the original publication in this journal is cited, in accordance with accepted academic practice.

No use, distribution or reproduction is permitted which does not comply with these terms. com ; Michael Sheetz, misheetz utmb. Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers.

Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Top bar navigation. About us About us. Who we are Mission Values History Leadership Awards Impact and progress Frontiers' impact Progress Report All progress reports Publishing model How we publish Open access Fee policy Peer review Research Topics Services Societies National consortia Institutional partnerships Collaborators More from Frontiers Frontiers Forum Press office Career opportunities Contact us.

Sections Sections. About journal About journal. Article types Author guidelines Editor guidelines Publishing fees Submission checklist Contact editorial office. Identification of rat pancreatic carcinoma genes associated with lymphogenous metastasis.

Anticancer Res. Mu, W. Host matrix modulation by tumor exosomes promotes motility and invasiveness. Neoplasia 15 , — Fabbri, M. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Natl Acad. USA , E—E Ye, S. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma.

Oncotarget 5 , Clayton, A. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Hood, J. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis.

Costa-Silva, B. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Hoshino, A. Tumour exosome integrins determine organotropic metastasis. Yue, S. The tetraspanins CD and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding.

Oncotarget 6 , PubMed Google Scholar. Luga, V. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.

Smyth, T. Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro. Acta , — Zoller, M. Tetraspanins: push and pull in suppressing and promoting metastasis. Cancer 9 , 40—55 Nanbo, A.

Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells. Mulcahy, L. Routes and mechanisms of extracellular vesicle uptake. Zhang, L. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth.

Kaur, A. Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility. Ecker, B. Age-related changes in HAPLN1 increase lymphatic permeability and affect routes of melanoma metastasis.

Flavahan, W. Epigenetic plasticity and the hallmarks of cancer. Helmink, B. The microbiome, cancer, and cancer therapy.

Pushalkar, S. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cronin, M. Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

Panebianco, C. Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies. Microbiome 6 , 92 Lehouritis, P. Local bacteria affect the efficacy of chemotherapeutic drugs. Geller, L. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.

Alexander, J. Gut microbiota modulation of chemotherapy efficacy and toxicity. Yu, T. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy.

Cell , — e Zheng, J. Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin. Kim, O. Bacterial outer membrane vesicles suppress tumor by interferon-gamma-mediated antitumor response.

Panda, A. Immune activation and benefit from Avelumab in EBV-positive gastric cancer. Natl Cancer Inst. Host, K. mBio 8 , e—e Smola, S. Immunopathogenesis of HPV-associated cancers and prospects for immunotherapy. Thiele Orberg, E. The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis.

Mucosal Immunol. Gur, C. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42 , — Masri, S.

The emerging link between cancer, metabolism, and circadian rhythms. Lie, J. Breast cancer and night work among Norwegian nurses. Cancer Causes Control. Papantoniou, K. Night shift work, chronotype and prostate cancer risk in the MCC-Spain case-control study. Int J.

Cancer , — Schernhammer, E. Knutsson, A. Breast cancer among shift workers: results of the WOLF longitudinal cohort study. Work Environ. Health 39 , — Straif, K. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. Kakizaki, M. Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study.

Cancer 99 , — Srour, B. Circadian nutritional behaviours and cancer risk: New insights from the NutriNet-sante prospective cohort study: disclaimers.

Altman, B. MYC disrupts the circadian clock and metabolism in cancer cells. Cell Metab. Huber, A. CRY2 and FBXL3 cooperatively degrade c-MYC. Shostak, A. Pascual, G. Targeting metastasis-initiating cells through the fatty acid receptor CD Nature , 41—45 Karamanos, N. Proteoglycan chemical diversity drives multifunctional cell regulation and therapeutics.

Frantz, C. The extracellular matrix at a glance. Cell Sci. Theocharis, A. Extracellular matrix structure. Drug Deliv. Maquart, F. An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity: implication in tumor invasion.

Sonnenschein, C. Carcinogenesis explained within the context of a theory of organisms. Maffini, M. The stroma as a crucial target in rat mammary gland carcinogenesis.

Barcellos-Hoff, M. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells.

Guerra, L. Stromal microenvironment in type VII collagen-deficient skin: The ground for squamous cell carcinoma development. Matrix Biol. Iozzo, R. Extracellular matrix: the driving force of mammalian diseases. Curran, S. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis.

Cancer 36 , — Kessenbrock, K. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell , 52—67 Moss, L. Matrix metalloproteinases changing roles in tumor progression and metastasis.

Egeblad, M. New functions for the matrix metalloproteinases in cancer progression. Cancer 2 , — Hadler-Olsen, E. Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets.

Tumor Biol. Elia, I. Breast cancer cells rely on environmental pyruvate to shape the metastatic niche. Du, W. The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis.

BMC Cancer 12 , Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor signaling. PLoS ONE 5 , e Cattaruzza, S. Iida, J. Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 pro-gelatinase A.

Biochem J. Karamanou, K. Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition.

Nikitovic, D. Lumican, a small leucine-rich proteoglycan. IUBMB Life. Brézillon, S. Lumican effects in the control of tumour progression and their links with metalloproteinases and integrins. FEBS J. Pietraszek, K. Lumican: a new inhibitor of matrix metalloproteinase activity.

FEBS Lett. Stasiak, M. Lumican inhibits SNAIL-induced melanoma cell migration specifically by blocking MMP activity. PLoS ONE 11 , e Pietraszek-Gremplewicz, K. Small leucine-rich proteoglycans and matrix metalloproteinase Key partners?

Filmus, J. The role of glypicans in Hedgehog signaling. Han, S. Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer. Oncotarget 7 , — PubMed PubMed Central Google Scholar. Lin, Q. Expression of GPC3 protein and its significance in lung squamous cell carcinoma.

Yu, X. Differential expression of glypican-3 GPC3 in lung squamous cell carcinoma and lung adenocarcinoma and its clinical significance. Genet Mol.

Zhang, Y. The role of GPC5 in lung metastasis of salivary adenoid cystic carcinoma. Williamson, D. Role for amplification and expression of glypican-5 in rhabdomyosarcoma.

Li, F. Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling. Korpetinou, A. Serglycin is implicated in the promotion of aggressive phenotype of breast cancer cells.

PLoS ONE 8 , e Bouris, P. Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling. Liu, T. NF-kappaB signaling in inflammation. Signal Transduct. Guo, J.

Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CDdependent manner. Oncogene 36 , — Chu, Q. Cell Death Dis. Roy, A. Targeting serglycin prevents metastasis in murine mammary carcinoma.

Purushothaman, A. Chondroitin sulfate proteoglycan serglycin influences protein cargo loading and functions of tumor-derived exosomes. Oncotarget 8 , — Passi, A. Dissecting the role of hyaluronan synthases in the tumor microenvironment. Chanmee, T. Hyaluronan: a modulator of the tumor microenvironment.

Cancer Lett. Zhang, Z. Hyaluronan synthase 2 expressed by cancer-associated fibroblasts promotes oral cancer invasion. Preca, B. Porsch, H. Efficient TGFbeta-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2.

Okuda, H. Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. Nagy, N. Hyaluronan in immune dysregulation and autoimmune diseases.

Piccioni, F. Glycobiology 25 , — Yates, T. Dietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer.

Schmaus, A. Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasis. Caon, I. Revisiting the hallmarks of cancer: The role of hyaluronan. Cancer Biol. pii: SX 19 —2 Misra, S. Interactions between hyaluronan and its receptors CD44, RHAMM regulate the activities of inflammation and cancer.

Wu, M. A novel role of low molecular weight hyaluronan in breast cancer metastasis. FASEB J. Du, Y. Low-molecular-weight hyaluronan LMW-HA accelerates lymph node metastasis of melanoma cells by inducing disruption of lymphatic intercellular adhesion.

Oncoimmunology 5 , e Mowers, E. Autophagy in cancer metastasis. Macintosh, R. Inhibition of autophagy impairs tumor cell invasion in an organotypic model. Cell Cycle 11 , — Mauffrey, P. Progenitors from the central nervous system drive neurogenesis in cancer.

Fares, J. Neurogenesis in the adult hippocampus: history, regulation, and prospective roles. Immune checkpoint inhibitors: Advances and impact in neuro-oncology.

Bidwell, B. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Natural killer cells in the brain tumor microenvironment: defining a new era in neuro-oncology. Pommier, A. Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases.

Science , Li, R. Reymond, N. Crossing the endothelial barrier during metastasis. Cancer 13 , — Bockhorn, M. Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? Zervantonakis, I. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function.

USA , — Wong, A. Mitosis-mediated intravasation in a tissue-engineered tumor-microvessel platform. Denais, C. Nuclear envelope rupture and repair during cancer cell migration. Hamidi, H. Every step of the way: integrins in cancer progression and metastasis. Cancer 18 , — Padmanaban, V.

E-cadherin is required for metastasis in multiple models of breast cancer. Pantel, K. The biology of circulating tumor cells. Oncogene 35 , — Gao, H. The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Lu, X. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging alpha4beta1-positive osteoclast progenitors.

Aceto, N. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. VN-NDP: a neighbor discovery protocol based on virtual nodes in mobile WSNs. Yu, M. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.

Ankrum, J. Mesenchymal stem cells: immune evasive, not immune privileged. Duda, D. Malignant cells facilitate lung metastasis by bringing their own soil.

Leach, J. Neutrophils: Homing in on the myeloid mechanisms of metastasis. Gay, L. Contribution of platelets to tumour metastasis.

Cancer 11 , — Placke, T. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells.

Hu, C. Thrombocytosis is a significant indictor of hypercoagulability, prognosis and recurrence in gastric cancer. Strilic, B. Intravascular survival and extravasation of tumor cells.

Cancer Cell 32 , — Leong, H. Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis. Cell Rep. Stoletov, K. Visualizing extravasation dynamics of metastatic tumor cells. Schumacher, D. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor.

Raskov, H. Premetastatic niches, exosomes and circulating tumor cells: Early mechanisms of tumor dissemination and the relation to surgery.

Cancer Smith, H. The metastasis-promoting roles of tumor-associated immune cells. Med Berl. Jackson, W. Role of megakaryocytes in breast cancer metastasis to bone. Granot, Z. Tumor entrained neutrophils inhibit seeding in the premetastatic lung.

Cancer Cell 20 , — Szczerba, B. Neutrophils escort circulating tumour cells to enable cell cycle progression. Obradovic, M. Glucocorticoids promote breast cancer metastasis. van Helvert, S. Mechanoreciprocity in cell migration. Follain, G. Hemodynamic forces tune the arrest, adhesion, and extravasation of circulating tumor cells.

Entenberg, D. A permanent window for the murine lung enables high-resolution imaging of cancer metastasis. Methods 15 , 73 Goetz, J. Metastases go with the flow. Exp Cell Res.

Matano M, Date S, Shimokawa M, Takano A, Fujii M, Ohta Y, Watanabe T, Kanai T, Sato T. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Nat Med. Gao D, Chen Y.

Organoid development in cancer genome discovery. Curr Opin Genet Dev. Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A, Sailer V, Augello M, Puca L, Rosati R, McNary TJ, Churakova Y, Cheung C, Triscott J, Pisapia D, Rao R, Mosquera JM, Robinson B, Faltas BM, Emerling BE, Gadi VK, Bernard B, Elemento O, Beltran H, Demichelis F, Kemp CJ, Grandori C, Cantley LC, Rubin MA.

Personalized in vitro and in vivo cancer models to guide precision medicine. Cancer Discov. van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A, van Houdt W, van Gorp J, Taylor-Weiner A, Kester L, McLaren-Douglas A, Blokker J, Jaksani S, Bartfeld S, Volckman R, van Sluis P, Li VS, Seepo S, Sekhar Pedamallu C, Cibulskis K, Carter SL, McKenna A, Lawrence MS, Lichtenstein L, Stewart C, Koster J, Versteeg R, van Oudenaarden A, Saez-Rodriguez J, Vries RG, Getz G, Wessels L, Stratton MR, McDermott U, Meyerson M, Garnett MJ, Clevers H.

Prospective derivation of a living organoid biobank of colorectal cancer patients. Weeber F, van de Wetering M, Hoogstraat M, Dijkstra KK, Krijgsman O, Kuilman T, Gadellaa-van Hooijdonk CG, van der Velden DL, Peeper DS, Cuppen EP, Vries RG, Clevers H, Voest EE.

Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases. Fujii M, Matano M, Toshimitsu K, Takano A, Mikami Y, Nishikori S, Sugimoto S, Sato T.

Human intestinal organoids maintain self-renewal capacity and cellular diversity in niche-inspired culture condition. Cell Stem Cell. Yuki K, Cheng N, Nakano M, Kuo CJ. Organoid models of tumor immunology.

Trends Immunol. Gunti S, Hoke ATK, Vu KP, London NR. Organoid and spheroid tumor models: techniques and applications. Cancers Basel. Ootani A, Li X, Sangiorgi E, Ho QT, Ueno H, Toda S, Sugihara H, Fujimoto K, Weissman IL, Capecchi MR, Kuo CJ.

Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche. Brennan MD, Rexius-Hall ML, Elgass LJ, Eddington DT. Oxygen control with microfluidics. Lab Chip. Verissimo CS, Overmeer RM, Ponsioen B, Drost J, Mertens S, Verlaan-Klink I, Gerwen BV, van der Ven M, Wetering MV, Egan DA, Bernards R, Clevers H, Bos JL, Snippert HJ.

Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening. Roper J, Tammela T, Cetinbas NM, Akkad A, Roghanian A, Rickelt S, Almeqdadi M, Wu K, Oberli MA, Sanchez-Rivera FJ, Park YK, Liang X, Eng G, Taylor MS, Azimi R, Kedrin D, Neupane R, Beyaz S, Sicinska ET, Suarez Y, Yoo J, Chen L, Zukerberg L, Katajisto P, Deshpande V, Bass AJ, Tsichlis PN, Lees J, Langer R, Hynes RO, Chen J, Bhutkar A, Jacks T, Yilmaz OH.

In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Weeber F, Ooft SN, Dijkstra KK, Voest EE. Tumor organoids as a pre-clinical cancer model for drug discovery.

Cell Chem Biol. Astashkina A, Grainger DW. Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments.

Adv Drug Deliv Rev. Skardal A, Devarasetty M, Rodman C, Atala A, Soker S. Liver-tumor hybrid organoids for modeling tumor growth and drug response in vitro.

Ann Biomed Eng. Dhandayuthapani B, Sakthi Kumar D. Biomaterials for biomedical applications. In: Biomedical Applications of Polymeric Materials and Composites. Malafaya PB, Silva GA, Reis RL. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications.

Kim BS, Mooney DJ. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol. Afewerki S, Sheikhi A, Kannan S, Ahadian S, Khademhosseini A. Gelatin-polysaccharide composite scaffolds for 3D cell culture and tissue engineering: Towards natural therapeutics.

Bioeng Transl Med. Liu W, Song J, Du X, Zhou Y, Li Y, Li R, Lyu L, He Y, Hao J, Ben J, Wang W, Shi H, Wang Q. AKR1B10 Aldo-keto reductase family 1 B10 promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model.

Artemenko Y, Swaney KF, Devreotes PN. Assessment of development and chemotaxis in Dictyostelium discoideum mutants. Wong MC, Martynovsky M, Schwarzbauer JE. Analysis of cell migration using Caenorhabditis elegans as a model system.

Stramer B, Wood W. Inflammation and wound healing in Drosophila. Xu T, Rubin GM. Analysis of genetic mosaics in developing and adult Drosophila tissues. Elks PM, Loynes CA, Renshaw SA. Measuring inflammatory cell migration in the zebrafish.

Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev Genet. Box GM, Eccles SA. Simple experimental and spontaneous metastasis assays in mice.

Lu J, Steeg PS, Price JE, Krishnamurthy S, Mani SA, Reuben J, Cristofanilli M, Dontu G, Bidaut L, Valero V, Hortobagyi GN, Yu D. Breast cancer metastasis: challenges and opportunities.

Talmadge JE. Models of metastasis in drug discovery. Roarty K, Echeverria GV. Laboratory models for investigating breast cancer therapy resistance and metastasis. Front Oncol. Gomez-Cuadrado L, Tracey N, Ma R, Qian B, Brunton VG. Mouse models of metastasis: progress and prospects.

Dis Model Mech. Fidler IJ. Selection of successive tumour lines for metastasis. Nat New Biol. Puchalapalli M, Zeng X, Mu L, Anderson A, Hix Glickman L, Zhang M, Sayyad MR, Mosticone Wangensteen S, Clevenger CV, Koblinski JE.

NSG mice provide a better spontaneous model of breast cancer metastasis than athymic Nude mice. Bankert RB, Balu-Iyer SV, Odunsi K, Shultz LD, Kelleher RJ Jr, Barnas JL, Simpson-Abelson M, Parsons R, Yokota SJ.

Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis. Cassidy JW, Caldas C, Bruna A.

Maintaining tumor heterogeneity in patient-derived tumor xenografts. Kuperwasser C, Dessain S, Bierbaum BE, Garnet D, Sperandio K, Gauvin GP, Naber SP, Weinberg RA, Rosenblatt M. A mouse model of human breast cancer metastasis to human bone. Morton JJ, Bird G, Refaeli Y, Jimeno A.

Humanized mouse xenograft models: narrowing the tumor-microenvironment gap. Day CP, Merlino G, Van Dyke T. Preclinical mouse cancer models: a maze of opportunities and challenges. Giacobbe A, Abate-Shen C. Modeling metastasis in mice: a closer look.

Trends Cancer. Khanna C, Hunter K. Modeling metastasis in vivo. Kersten K, de Visser KE, van Miltenburg MH, Jonkers J. Genetically engineered mouse models in oncology research and cancer medicine. EMBO Mol Med. Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau CS, Verstegen NJM, Ciampricotti M, Hawinkels L, Jonkers J, de Visser KE.

ILproducing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Doornebal CW, Klarenbeek S, Braumuller TM, Klijn CN, Ciampricotti M, Hau CS, Hollmann MW, Jonkers J, de Visser KE.

A preclinical mouse model of invasive lobular breast cancer metastasis. Kim HS, Kim HJ, Lee MR, Han I. EMMPRIN expression is associated with metastatic progression in osteosarcoma. BMC Cancer. Luo S, Wang H, Bai L, Chen Y, Chen S, Gao K, Wang H, Wu S, Song H, Ma K, Liu M, Yao F, Fang Y, Xiao Q.

J Adv Res. Lu ZH, Kaliberov S, Sohn RE, Kaliberova L, Du Y, Prior JL, Leib DJ, Chauchereau A, Sehn JK, Curiel DT, Arbeit JM. A new model of multi-visceral and bone metastatic prostate cancer with perivascular niche targeting by a novel endothelial specific adenoviral vector. Melo KP, Makela AV, Knier NN, Hamilton AM, Foster PJ.

Magnetic microspheres can be used for magnetic particle imaging of cancer cells arrested in the mouse brain. Magn Reson Med. Tanaka M, Dykes SS, Siemann DW. Inhibition of the Axl pathway impairs breast and prostate cancer metastasis to the bones and bone remodeling.

Clin Exp Metastasis. Paschall AV, Liu K. An orthotopic mouse model of spontaneous breast cancer metastasis. Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, Li P, Li M, Wang X, Zhang C, Wang H, Ellis K, Cheerathodi M, McCarty JH, Palmieri D, Saunus J, Lakhani S, Huang S, Sahin AA, Aldape KD, Steeg PS, Yu D.

Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Zhang W, Bado IL, Hu J, Wan YW, Wu L, Wang H, Gao Y, Jeong HH, Xu Z, Hao X, Lege BM, Al-Ouran R, Li L, Li J, Yu L, Singh S, Lo HC, Niu M, Liu J, Jiang W, Li Y, Wong STC, Cheng C, Liu Z, Zhang XH.

The bone microenvironment invigorates metastatic seeds for further dissemination. Fidler IJ, Hart IR. Biological diversity in metastatic neoplasms: origins and implications. Murugaesu N, Iravani M, van Weverwijk A, Ivetic A, Johnson DA, Antonopoulos A, Fearns A, Jamal-Hanjani M, Sims D, Fenwick K, Mitsopoulos C, Gao Q, Orr N, Zvelebil M, Haslam SM, Dell A, Yarwood H, Lord CJ, Ashworth A, Isacke CM.

An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressor. van der Weyden L, Arends MJ, Campbell AD, Bald T, Wardle-Jones H, Griggs N, Velasco-Herrera MD, Tuting T, Sansom OJ, Karp NA, Clare S, Gleeson D, Ryder E, Galli A, Tuck E, Cambridge EL, Voet T, Macaulay IC, Wong K, Sanger Mouse Genetics P, Spiegel S, Speak AO, Adams DJ.

Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Borowsky AD, Namba R, Young LJ, Hunter KW, Hodgson JG, Tepper CG, McGoldrick ET, Muller WJ, Cardiff RD, Gregg JP. Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior.

Jung J, Lee CH, Seol HS, Choi YS, Kim E, Lee EJ, Rhee JK, Singh SR, Jun ES, Han B, Hong SM, Kim SC, Chang S. Generation and molecular characterization of pancreatic cancer patient-derived xenografts reveals their heterologous nature. Jung J, Seol HS, Chang S.

The generation and application of patient-derived xenograft model for cancer research. Cancer Res Treat. Sheth RA, Perkons N, Dondossola E, Subudhi SK, Gade TP, Tam AL.

Patient-derived xenograft tumor models: overview and relevance to IR. J Vasc Interv Radiol. Lee YC, Lin SC, Yu G, Zhu M, Song JH, Rivera K, Pappin DJ, Logothetis CJ, Panaretakis T, Wang G, Yu-Lee LY, Lin SH.

DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, Ebbert MT, Factor R, Matsen C, Milash BA, Nelson E, Neumayer L, Randall RL, Stijleman IJ, Welm BE, Welm AL.

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Gills J, Moret R, Zhang X, Nelson J, Maresh G, Hellmers L, Canter D, Hudson M, Halat S, Matrana M, Marino MP, Reiser J, Shuh M, Laborde E, Latsis M, Talwar S, Bardot S, Li L.

A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis. Patient-derived xenografts—PDX models. Charles River Laboratories International, Inc.

Accessed 15 Dec Patient-derived xenograft PDX models. The Jackson Laboratory. Hoffman RM. Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts.

Solaimuthu B, Hayashi A, Khatib A, Shaul YD. Monitoring breast cancer growth and metastatic colony formation in mice using bioluminescence. All About Metastatic Cancer. Accessed 5 Oct Burley TA, Hesketh A, Bucca G, Kennedy E, Ladikou EE, Towler BP, Mitchell S, Smith CP, Fegan C, Johnston R, Pepper A, Pepper C.

Elucidation of focal adhesion kinase as a modulator of migration and invasion and as a potential therapeutic target in chronic lymphocytic leukemia. Fertal SA, Zaidi SK, Stein JL, Stein GS, Heath JL.

CXCR4 mediates enhanced cell migration in CALM-AF10 leukemia. Luo H, Sun R, Zheng Y, Huang J, Wang F, Long D, Wu Y. PIM3 promotes the proliferation and migration of acute myeloid leukemia cells. Onco Targets Ther.

Macanas-Pirard P, Quezada T, Navarrete L, Broekhuizen R, Leisewitz A, Nervi B, Ramirez PA. Voermans C, van Heese WP, de Jong I, Gerritsen WR, van Der Schoot CE. Migratory behavior of leukemic cells from acute myeloid leukemia patients.

Feng S, Cen J, Huang Y, Shen H, Yao L, Wang Y, Chen Z. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.

Zippel Sabrina RA, Lee-Thedieck C. Migration Assay for Leukemic Cells in a 3D Matrix Toward a Chemoattractant. Springer; Walsby E, Buggins A, Devereux S, Jones C, Pratt G, Brennan P, Fegan C, Pepper C.

Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemia. Skroblyn T, Joedicke JJ, Pfau M, Kruger K, Bourquin JP, Izraeli S, Eckert C, Hopken UE.

CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment. Madrazo E, Gonzalez-Novo R, Ortiz-Placin C, Garcia de Lacoba M, Gonzalez-Murillo A, Ramirez M, Redondo-Munoz J. Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells.

Antoni D, Burckel H, Josset E, Noel G. Three-dimensional cell culture: a breakthrough in vivo. Jensen C, Teng Y. Is it time to start transitioning from 2D to 3D cell culture?

Front Mol Biosci. Sherman H, Gitschier HJ, Rossi AE. A novel three-dimensional immune oncology model for high-throughput testing of tumoricidal activity. Front Immunol. Dish CC. A look towards the future of 3D cell culture—a panel discussion.

cell culture dish. Lee MW, Miljanic M, Triplett T, Ramirez C, Aung KL, Eckhardt SG, Capasso A. Current methods in translational cancer research.

Cancer Metastasis Rev. Thermo Fisher Scientific. Accessed 11 Apr CIM-Plate 16 by Agilent Technologies. Select Science. Download references. This work was supported by Ministry of Health of the Czech Republic, grant nr.

NV, all rights reserved. Supported by the project National Institute for Cancer Research Programme EXCELES, ID Project No. LX22NPO —Funded by the European Union—Next Generation EU. Department of Biochemistry, Faculty of Science, Masaryk University, Kamenice 5, , Brno, Czech Republic.

You can also search for this author in PubMed Google Scholar. PBouchalova wrote the main manuscript text and prepared all figures.

PBouchal acquired funding and finalized the manuscript. Both authors reviewed the manuscript. Correspondence to Pavel Bouchal. Authors declare that they have not conflict of interests with the content of the manuscript and do not receive financial benefit from companies named in the manuscript.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Open Access This article is licensed under a Creative Commons Attribution 4.

The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Reprints and permissions. Bouchalova, P. Current methods for studying metastatic potential of tumor cells. Cancer Cell Int 22 , Download citation. Received : 27 July Accepted : 22 November Published : 09 December Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Skip to main content. Search all BMC articles Search. Download PDF. Abstract Cell migration and invasiveness significantly contribute to desirable physiological processes, such as wound healing or embryogenesis, as well as to serious pathological processes such as the spread of cancer cells to form tumor metastasis.

Introduction Cell migration and invasiveness play an essential role in a number of biological processes such as embryogenesis, immune response, wound healing, morphogenesis and inflammation [ 1 ]. Full size image. Simple in vitro methods to study cell migration Time-lapse microscopy The easiest way to quantify the migration of individual cells is by monitoring their movement using light microscopy at defined time intervals Fig.

In vitro methods to study cell migration based on chemotaxis Chemotaxis is directional cell movement in an extracellular chemical gradient of various compounds, and is of great importance in many biological processes, including the formation of metastases [ 23 ].

Dunn chamber The Dunn chamber is a tool that allows the microscopic observation of cell migration in response to the presence of a chemoattractant in real time [ 25 ]. Videomicroscopy of cells Videomicroscopy allows the continuous visualization and quantification of chemotaxis, especially in adherent mammalian cells, such as tumor or endothelial cells [ 30 ].

Surface coating materials to improve cell adhesion The wellbeing of adherent cells in the culture is influenced by their attachment to a substrate. In vitro methods to study cell migration and invasiveness based on Boyden chamber Cell migration in Boyden chamber The Boyden chamber was originally developed to study leukocyte chemotaxis, and has become a suitable tool for observing the motility and invasiveness of tumor cells [ 27 ].

Matrices mimicking ECM environment to study cell invasiveness To study cell invasiveness, the application of matrices mimicking the natural composition of the ECM is essential to preparing a suitable 3D hydrogel environment that supports appropriate cell growth, invasion and the formation of multicellular structures.

Cell invasion using Boyden chamber Further, the Boyden chamber can be modified to study the invasive properties of tumor cells by covering the microporous membrane with a layer which composition is close to the ECM to form a three-dimensional 3D environment.

xCELLigence system—a real-time analysis of migration and invasiveness The xCELLigence system is a well-established technology based on the principle of the Boyden chamber that allows the real-time monitoring of cell motility.

Confocal microscopy The implementation of confocal microscopy into routine practice in recent years has made it possible to study various cellular processes and sub-cellular structures in detail and enabled the movement of cells in space and time to be recorded [ 52 ]. Multiphoton microscopy The most commonly used version of multiphoton microscopy is two-photon microscopy [ 56 ].

Light sheet fluorescent microscopy LSFM In this type of microscopy, the expanded laser beam passing through a cylindrical lens is focused onto a thin light sheet perpendicular to the direction of observation [ 63 , 64 ]. ECM degradation assay The invasion of tumor cells into the surrounding ECM is one of the key steps in the metastatic cascade.

Studying cell migration in microchannels Studying cell migration in precisely defined microchannels of various dimensions, with or without inserted constrictions [ 76 , 77 ] is a universal and simple method with the option of coating the microchannel surface with various substrates that affect the adhesivity of the migrating cells [ 33 ].

Co-culture migration test Co-culture migration test combines the cultivation of tumor and normal stromal cells such as fibroblasts, epithelial cells, or macrophages in a microfluidic co-culture device to simulate the environment in a real tumor, where various types of cells are combined and influence each other via both chemical signals and direct contacts.

Microfluidics-based extravasation assays Microfluidics-based extravasation assays were developed to study the extravasation of tumor cells in a perfusing microvascular network.

Models for studying metastasis in vivo In vivo testing is an essential part of research in the field of cancer biology, i. Mice—the unrivalled in vivo model in tumor biology However, the most commonly used organism to study the mechanisms of tumor formation, tumor growth and metastatic cascade processes in vivo is the domestic mouse Mus musculus [ , , ].

Genetically engineered mice models GEMMs Fig. Study of migration and invasiveness in non-solid malignancies Neoplastic malignancies of hematopoietic or lymphatic tissues including leukemia, lymphoma or myeloma are—due to their natural spread to the whole body in the bloodstream or lymph system—considered to be metastatic at the time of diagnosis [ ].

Future directions The use of 3D techniques in cancer research is a leading topic that is providing new data and revealing the unknown consequences.

Availability of data and materials Not applicable. References Vicente-Manzanares M, Horwitz AR. Article CAS Google Scholar Patel LR, Camacho DF, Shiozawa Y, Pienta KJ, Taichman RS. Article CAS Google Scholar Valastyan S, Weinberg RA. Article CAS Google Scholar Maryas J, Faktor J, Dvorakova M, Struharova I, Grell P, Bouchal P.

Article CAS Google Scholar Penet MF, Chen Z, Bhujwalla ZM. Article Google Scholar Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Article Google Scholar Faktor J, Dvorakova M, Maryas J, Struharova I, Bouchal P. Google Scholar Hsieh TC, Wu JM. Article Google Scholar Cory G.

Article CAS Google Scholar Eccles SA, Box C, Court W. Article CAS Google Scholar Magdalena J, Millard TH, Etienne-Manneville S, Launay S, Warwick HK, Machesky LM.

Article CAS Google Scholar Sigma-Aldrich. Google Scholar Vang Mouritzen M, Jenssen H. Article Google Scholar Glenn HL, Messner J, Meldrum DR. Article CAS Google Scholar Block ER, Matela AR, SundarRaj N, Iszkula ER, Klarlund JK.

Article CAS Google Scholar Nikolic DL, Boettiger AN, Bar-Sagi D, Carbeck JD, Shvartsman SY. Article CAS Google Scholar Poujade M, Grasland-Mongrain E, Hertzog A, Jouanneau J, Chavrier P, Ladoux B, Buguin A, Silberzan P.

Article CAS Google Scholar Gough W, Hulkower KI, Lynch R, McGlynn P, Uhlik M, Yan L, Lee JA. Article Google Scholar Guy R.

Article CAS Google Scholar Thiery JP. Article CAS Google Scholar Cooper CR, Pienta KJ. Article CAS Google Scholar Roussos ET, Condeelis JS, Patsialou A.

Article CAS Google Scholar Zicha D, Dunn GA, Brown AF. Article CAS Google Scholar Muinonen-Martin AJ, Veltman DM, Kalna G, Insall RH.

Article CAS Google Scholar Zigmond SH. Article CAS Google Scholar Zantl R, Horn E. Article CAS Google Scholar IBIDI.

Accessed 31 Aug Keurhorst D, Liashkovich I, Frontzek F, Nitzlaff S, Hofschroer V, Dreier R, Stock C. Article Google Scholar Vargas P, Terriac E, Lennon-Dumenil AM, Piel M. Article Google Scholar IBIDI.

Article CAS Google Scholar Merck-Millipore Boyden chamber technique. Accessed 06 September Frantz C, Stewart KM, Weaver VM. Article CAS Google Scholar Hughes CS, Postovit LM, Lajoie GA.

Article CAS Google Scholar ThermoFisherScientific. Article CAS Google Scholar Marshall J. Accessed 16 Nov Limame R, Wouters A, Pauwels B, Fransen E, Peeters M, Lardon F, De Wever O, Pauwels P.

Article CAS Google Scholar Agilent. Article CAS Google Scholar Jonkman J, Brown CM, Wright GD, Anderson KI, North AJ. Article Google Scholar Perrin L, Bayarmagnai B, Gligorijevic B. Google Scholar Dunn KW, Young PA. Article Google Scholar Konig K. Article CAS Google Scholar Robinson JP.

Article CAS Google Scholar Zong W, Wu R, Li M, Hu Y, Li Y, Li J, Rong H, Wu H, Xu Y, Lu Y, Jia H, Fan M, Zhou Z, Zhang Y, Wang A, Chen L, Cheng H. Article CAS Google Scholar Fumagalli A, Drost J, Suijkerbuijk SJ, van Boxtel R, de Ligt J, Offerhaus GJ, Begthel H, Beerling E, Tan EH, Sansom OJ, Cuppen E, Clevers H, van Rheenen J.

Article CAS Google Scholar Nedosekin DA, Verkhusha VV, Melerzanov AV, Zharov VP, Galanzha EI. Article CAS Google Scholar Adams MW, Loftus AF, Dunn SE, Joens MS, Fitzpatrick JAJ.

Google Scholar Greger K, Swoger J, Stelzer EH. Article CAS Google Scholar Pan C, Schoppe O, Parra-Damas A, Cai R, Todorov MI, Gondi G, von Neubeck B, Bogurcu-Seidel N, Seidel S, Sleiman K, Veltkamp C, Forstera B, Mai H, Rong Z, Trompak O, Ghasemigharagoz A, Reimer MA, Cuesta AM, Coronel J, Jeremias I, Saur D, Acker-Palmer A, Acker T, Garvalov BK, Menze B, Zeidler R, Erturk A.

Google Scholar Tomer R, Lovett-Barron M, Kauvar I, Andalman A, Burns VM, Sankaran S, Grosenick L, Broxton M, Yang S, Deisseroth K. Article CAS Google Scholar Albert-Smet I, Marcos-Vidal A, Vaquero JJ, Desco M, Munoz-Barrutia A, Ripoll J.

Article CAS Google Scholar Merz SF, Jansen P, Ulankiewicz R, Bornemann L, Schimming T, Griewank K, Cibir Z, Kraus A, Stoffels I, Aspelmeier T, Brandau S, Schadendorf D, Hadaschik E, Ebel G, Gunzer M, Klode J.

Article Google Scholar Glaser AK, Bishop KW, Barner LA, Susaki EA, Kubota SI, Gao G, Serafin RB, Balaram P, Turschak E, Nicovich PR, Lai H, Lucas LAG, Yi Y, Nichols EK, Huang H, Reder NP, Wilson JJ, Sivakumar R, Shamskhou E, Stoltzfus CR, Wei X, Hempton AK, Pende M, Murawala P, Dodt HU, Imaizumi T, Shendure J, Beliveau BJ, Gerner MY, Xin L, Zhao H, True LD, Reid RC, Chandrashekar J, Ueda HR, Svoboda K, Liu JTC.

Article CAS Google Scholar Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC. Article CAS Google Scholar Fontana R, Yang J. Article CAS Google Scholar Jerrell RJ, Parekh A. Article CAS Google Scholar Martin KH, Hayes KE, Walk EL, Ammer AG, Markwell SM, Weed SA. Article Google Scholar Bhatia SN, Ingber DE.

Article CAS Google Scholar Sontheimer-Phelps A, Hassell BA, Ingber DE. Article CAS Google Scholar Friedl P, Wolf K. Article CAS Google Scholar Heuze ML, Collin O, Terriac E, Lennon-Dumenil AM, Piel M. Article CAS Google Scholar Wang M, Cheng B, Yang Y, Liu H, Huang G, Han L, Li F, Xu F.

Article CAS Google Scholar Ma H, Liu T, Qin J, Lin B. Article CAS Google Scholar Mi S, Du Z, Xu Y, Wu Z, Qian X, Zhang M, Sun W. Article CAS Google Scholar Chen MB, Lamar JM, Li R, Hynes RO, Kamm RD. Article CAS Google Scholar Chandrasekaran S, Geng Y, DeLouise LA, King MR.

Article CAS Google Scholar Weiswald LB, Bellet D, Dangles-Marie V. Article Google Scholar Sant S, Johnston PA. Article Google Scholar Jensen C, Shay C, Teng Y.

Article Google Scholar Bjerkvig R, Tonnesen A, Laerum OD, Backlund EO. Article CAS Google Scholar Salmaggi A, Boiardi A, Gelati M, Russo A, Calatozzolo C, Ciusani E, Sciacca FL, Ottolina A, Parati EA, La Porta C, Alessandri G, Marras C, Croci D, De Rossi M.

Article Google Scholar Weiswald LB, Richon S, Validire P, Briffod M, Lai-Kuen R, Cordelieres FP, Bertrand F, Dargere D, Massonnet G, Marangoni E, Gayet B, Pocard M, Bieche I, Poupon MF, Bellet D, Dangles-Marie V. Article CAS Google Scholar Yuhas JM, Li AP, Martinez AO, Ladman AJ.

CAS Google Scholar Dangles-Marie V, Pocard M, Richon S, Weiswald LB, Assayag F, Saulnier P, Judde JG, Janneau JL, Auger N, Validire P, Dutrillaux B, Praz F, Bellet D, Poupon MF.

Cancer Cell International volume 22Article Herbal weight loss capsules Cite this article. Metrics details. Sustainable weight loss migration and invasiveness significantly contribute metastawis desirable Mood boosting exercises processes, cancfr as wound healing or Inhibiting cancer cell metastasis, as well as cxncer serious pathological processes such as cancerr Inhibiting cancer cell metastasis of cancer cells to form tumor metastasis. The availability of appropriate methods for studying these processes is essential for understanding the molecular basis of cancer metastasis and for identifying suitable therapeutic targets for anti-metastatic treatment. The in vivo methods are mostly based on mice, allowing genetically engineered mice models and transplant models syngeneic mice, cell line-derived xenografts and patient-derived xenografts including humanized mice models. These methods currently represent a solid basis for the state-of-the art research that is focused on understanding metastatic fundamentals as well as the development of targeted anti-metastatic therapies, and stratified treatment in oncology. Over time, tumor cells land metastaais other locations and form a cluster Inhibiting cancer cell metastasis celk cells. Dysregulated cells continue to csll and wreak additional havoc Inhibitihg branching out, Strong anti-viral organs and tissues throughout cancre body. That goal Role of free radicals been the focus meyastasis research teams celll the VCU Institute of Molecular Medicine VIMM and VCU Massey Comprehensive Cancer Center, which are developing novel ways of targeting the processes that fuel such unregulated cell growth and stopping the expansion of cancer cells before they take root in other parts of the body. Fisher, M. Fisher holds the Thelma Newmeyer Corman Chair in Cancer Research at Massey. He founded the VIMM at the School of Medicine and has served as its director since He co-founded the Cancer Molecular Genetics research program at Massey and helped lead it for nine years.